Anaplastic Large Cell Lymphoma (ALCL)
Anaplastic Large Cell Lymphoma (ALCL) is a type of non-Hodgkin lymphoma that can affect lymph nodes and other organs, characterized by the presence of large, abnormal lymphocytes.
Brigatinib for Pediatric and Young Adult ALK+ Cancer
We are studying the safety and effectiveness of brigatinib in children and young adults with ALK+ Anaplastic Large Cell Lymphoma and other solid tumors. This trial aims to find the best dose and understand how the drug works in these patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Inflammatory Myofibroblastic Tumors (IMT)
Inflammatory Myofibroblastic Tumors (IMT) are rare tumors that can occur in various parts of the body, often causing swelling and inflammation, and are characterized by myofibroblastic cells.
Other Solid Tumors
Other solid tumors refer to a variety of abnormal growths that can occur in different tissues of the body, which may be benign or malignant.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 1 and 25 years old?
- Do you have a confirmed diagnosis of cancer?
- Are you currently taking any medications that are strong or moderate CYP3A inhibitors or inducers, like Ketoconazole or Rifampin?
- Do you have another active cancer besides the one being treated?
- Are you able to swallow tablets?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
St. Anna Kinderspital GmbH
Department of Pediatric Hematology and Oncology
Vienna, Austria
Universitair Ziekenhuis Gent
Pediatric Hemato-Oncology & Stem Cell Transplantation
Ledeberg, Belgium
Fakultni Nemocnice V Motole
Klinika detske hematologie a onkologie 2. LF UK
Stodůlky, Czechia
Sponsor: Prinses Maxima Centrum voor Kinderoncologie B.V.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.